| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $644.2M | — | +5.3% |
| Cost of Revenue | $179.4M | — | -0.6% |
| Gross Profit | $464.8M | — | +7.7% |
| R&D Expense | $81.7M | — | -0.3% |
| SG&A Expense | $60.2M | — | -6.5% |
| Operating Income | $50.0M | — | +383.8% |
| Interest Expense | $14.1M | — | -8.8% |
| Pre-tax Income | $34.1M | — | +880.0% |
| Income Tax | $3.5M | — | -41.4% |
| Net Income | $30.6M | — | +396.5% |
| EPS (Basic) | $0.36 | — | +427.3% |
| EPS (Diluted) | $0.35 | — | +418.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $116.6M | -12.1% | -24.5% |
| Accounts Receivable | $362.5M | -5.6% | -4.9% |
| Inventory | $1.0M | +7.8% | -14.4% |
| Current Assets | $727.8M | -4.9% | -6.7% |
| Total Assets | $1.42B | -4.0% | -12.9% |
| Current Liabilities | $635.4M | -47.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $164.0M | — | +9.6% |
| Capital Expenditures | $6.5M | — | +17.1% |
| Investing Cash Flow | -$31.3M | — | -60.8% |
| Financing Cash Flow | -$147.5M | — | +32.9% |
| Free Cash Flow | $157.5M | — | +9.3% |
| -47.4% |
| Long-term Debt | $1.16B | +84.2% | +57.5% |
| Total Liabilities | $1.83B | -2.1% | -7.2% |
| Stockholders' Equity | -$609.3M | -3.6% | -12.6% |